Reactive and Regulative Temperament in Relation to Clinical Symptomatology and Personality Disorders in Patients with a Substance Use Disorder.

behavioral activation behavioral inhibition clinical symptoms effortful control personality disorders substance use disorders

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
25 Jan 2022
Historique:
received: 05 11 2021
revised: 13 01 2022
accepted: 20 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 16 2 2022
Statut: epublish

Résumé

Temperament and personality traits are important factors underlying the vulnerability for both the initiation and continuation of addictive behaviors. We investigated the influence of reactive and regulative temperament and their interaction in relation to clinical symptomatology and personality disorders (PDs) in a sample of 841 inpatients (68.1% males) with a substance use disorder (SUD). To assess reactive temperament we used the Behavioral Inhibition and Behavioral Activation Scales (BISBAS) and to assess regulative temperament we used the Effortful Control Scale. Clinical symptomatology and personality traits were measured by means of the Symptom Checklist-90 (SCL-90) and the Assessment of ADP-IV Personality Disorders (ADP-IV). Hierarchical regression analyses showed that both, clinical symptomatology and PDs were related to low levels of effortful control (EC). None of the two-way interactions (BIS × EC, BAS × EC) however were significantly related to psychopathology. Current findings highlight the role of effortful control (EC) in the expression of psychopathology in an adult sample of inpatients with SUD. Therapeutic interventions aiming at strengthening EC can possibly result in better treatment outcomes for both the addiction and the comorbid psychopathology.

Identifiants

pubmed: 35160046
pii: jcm11030591
doi: 10.3390/jcm11030591
pmc: PMC8837055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Neuropsychobiology. 2020;79(4-5):255-269
pubmed: 32106115
Alcohol Res. 2019 Dec 30;40(1):
pubmed: 31886106
Exp Clin Psychopharmacol. 2004 Feb;12(1):65-75
pubmed: 14769101
Psychol Med. 2004 May;34(4):597-611
pubmed: 15099415
Compr Psychiatry. 2013 Jul;54(5):454-61
pubmed: 23332552
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):395-422
pubmed: 16492265
Drug Alcohol Depend. 2016 Aug 01;165:283-7
pubmed: 27318372
Alcohol Clin Exp Res. 2013 Jun;37(6):1040-7
pubmed: 23421347
Psychol Addict Behav. 2004 Sep;18(3):275-83
pubmed: 15482083
Front Psychol. 2017 Feb 17;8:231
pubmed: 28261148
Int J Neuropsychopharmacol. 2017 Dec 1;20(12):1036-1046
pubmed: 29106542
Alcohol Clin Exp Res. 1994 Aug;18(4):852-60
pubmed: 7978095
Addiction. 2001 Aug;96(8):1175-85
pubmed: 11487423
Front Psychol. 2015 Mar 26;6:328
pubmed: 25859234
Clin Psychol Rev. 2009 Jul;29(5):421-30
pubmed: 19403216
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
J Clin Child Adolesc Psychol. 2004 Mar;33(1):8-20
pubmed: 15028537
Lancet Psychiatry. 2020 Jun;7(6):506-514
pubmed: 32445689
J Abnorm Psychol. 2004 May;113(2):302-14
pubmed: 15122950
Am J Psychiatry. 2014 May;171(5):510-22
pubmed: 24700194
Psychol Addict Behav. 2015 Dec;29(4):864-74
pubmed: 26348221
Child Adolesc Psychiatry Ment Health. 2016 Apr 11;10:8
pubmed: 27069507
Alcohol Res. 2019 Jan 01;40(1):
pubmed: 31649834
Acta Psychiatr Scand Suppl. 2004;(420):21-7
pubmed: 15128384
Actas Esp Psiquiatr. 2012 Nov-Dec;40(6):315-22
pubmed: 23165414
JAMA Psychiatry. 2013 Jul;70(7):718-26
pubmed: 23636710
Dev Psychopathol. 2007 Spring;19(2):523-39
pubmed: 17459182
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Neurosci Biobehav Rev. 2016 Sep;68:270-281
pubmed: 27236041
Compr Psychiatry. 2006 May-Jun;47(3):227-33
pubmed: 16635653
Clin Psychol Rev. 2010 Aug;30(6):621-34
pubmed: 20546986
J Health Psychol. 2010 May;15(4):515-25
pubmed: 20460408
Dialogues Clin Neurosci. 2019 Sep;21(3):281-290
pubmed: 31749652
Addiction. 2019 Jun;114(6):1095-1109
pubmed: 30133930
Borderline Personal Disord Emot Dysregul. 2018 Sep 19;5:15
pubmed: 30250740
Neurosci Biobehav Rev. 2004 May;28(3):317-32
pubmed: 15225974
Nat Rev Neurosci. 2013 Sep;14(9):609-25
pubmed: 23942470
Front Psychiatry. 2019 May 22;10:311
pubmed: 31178763
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Front Psychiatry. 2021 Mar 04;12:644882
pubmed: 33746802
Pers Soc Psychol Rev. 2004;8(3):220-47
pubmed: 15454347
J Affect Disord. 2018 Dec 1;241:388-401
pubmed: 30145509
J Child Psychol Psychiatry. 2017 Apr;58(4):361-383
pubmed: 28035675
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
Personal Disord. 2015 Oct;6(4):301-9
pubmed: 26147068
Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109118
pubmed: 34688166
Am J Psychiatry. 2017 Jul 1;174(7):676-685
pubmed: 28320224
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
J Res Pers. 2011 Oct;45(5):430-440
pubmed: 22581988
Addiction. 2018 May;113(5):924-934
pubmed: 29284197
N Engl J Med. 2016 Jan 28;374(4):363-71
pubmed: 26816013

Auteurs

Els Santens (E)

Alexian Psychiatric Hospital, 3300 Tienen, Belgium.
Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Geert Dom (G)

Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Multiversum Psychiatric Hospital, 2530 Boechout, Belgium.

Eva Dierckx (E)

Alexian Psychiatric Hospital, 3300 Tienen, Belgium.
Developmental and Life Span Psychology, Vrije Universiteit Brussel, 1050 Brussels, Belgium.

Laurence Claes (L)

Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Faculty of Psychology and Educational Science, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.

Classifications MeSH